Investigating the Synergistic Effects of Chitosan and Dexamethasone in the Management of Periapical Inflammation: A Computational Perspective
Keywords:
chitosan, anti-inflammatory, molecular docking, RAW 264.7 macrophagesAbstract
Chitosan, a natural biopolymer, is known for its biocompatibility and anti-inflammatory properties, positioning it as a promising alternative to conventional anti-inflammatory agents. This study aims to evaluate and compare the anti-inflammatory efficacy of chitosan with that of dexamethasone, focusing on molecular docking analysis and in-vitro assays. The anti-inflammatory effects of chitosan and dexamethasone were assessed using cultured RAW 264.7 macrophages treated at various concentrations after LPS-induced inflammation. Inflammatory markers TNF-α, IL-6, and nitric oxide (NO) were quantified via ELISA and Griess assays. Additionally, molecular docking studies targeting iNOS, ALOX5, MAPK, PKC, ERK, and TNF-α were performed to compare binding affinities. In vitro, dexamethasone exhibited a stronger anti-inflammatory effect than chitosan, with a lower IC50 (22.7 µg/mL versus 40.3 µg/mL for chitosan). At maximum concentration, dexamethasone inhibited inflammation by 90%, compared to 80% for chitosan. Docking studies further demonstrated that dexamethasone had consistently stronger binding affinities with all targets, particularly iNOS and ALOX5. While dexamethasone's potency surpasses that of chitosan, chitosan’s moderate anti-inflammatory efficacy and natural origin make it a promising complementary agent. The findings suggest potential applications of chitosan in cases where synthetic drugs may cause side effects or are unsuitable for long-term use.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Gokulapriyan Karuppiah , Ramya Ramadoss, Nitya Krishnasamy, Adhithiya Palaniswamy, Mayuri Rapeti, Jaganiya Sekar (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Licensing
All articles published in Trends in Biomaterials and Artificial Organs are published Open Access. To ensure the widest possible dissemination of research while protecting the integrity of the original work, we utilize the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 4.0 International License.
User Rights
Under this license, the public is free to share (copy and redistribute the material in any medium or format) under the following terms:
- Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made.
- Non-Commercial: Users may not use the material for commercial purposes. This includes, but is not limited to, the sale of the article or its use in promotional materials for-profit.
- No Derivatives: If a user remixes, transforms, or builds upon the material, they may not distribute the modified material.
Author Rights
Authors retain copyright of their work while granting the journal a non-exclusive license to publish. Because of the NoDerivs (ND) and Non-Commercial (NC) designations:
- Third parties (such as other researchers) must seek permission from the authors/journal to include figures, tables, or portions of the text in new works or commercial publications.
- Authors may deposit the "Version of Record" in institutional repositories immediately upon publication, provided the CC BY-NC-ND 4.0 license is clearly linked.
